Abstract:
A method for preparing cholesterol reducing, edible products, whereby plant sterols or plant stanols having cholesterol reducing properties are dissolved or mixed in a melt of a food emulsifier in a relationship between the emulsifier and sterol/stanol which is higher than 1:1, preferably 2:1, said solution or mixture is admixed into a protein containing product at a temperature of 45-100 DEG C, or preferably 60-85 DEG C, the mixture is homogenized at a pressure drop of 50-1000 bar, or preferably 100-250 bar, whereby a solution of liposome particles containing sterols/stanols is formed in the protein containing product, and the resulting sterol/stanol containing liposome mixture is admixed into food products in an amount of 0.1-10 % by weight, or preferably an amount of 1-3 % by weight of the product.The invention also relates to an edible product having an additive of the cholesterol reducing product, encased in liposomes, preferably used as an additive in milk, in milk intended to be curdled to cheese of different types, in cooking fat, in yoghurt, in acidified milk products, in powdered milk, in cream powder, in chocolate drink powder, in gruels, in health food products, in pharmacological preparations, etc.
Abstract:
The present invention relates to an oral formulation to lower serum or hepatic lipid and triglyceride concentrations, hepatic inflammation and/or insulin resistance in a patient comprising live feruloyl esterase producing microorganisms alone or in association with a pharmaceutically acceptable carrier resistant to gastric conditions, and wherein the microorganisms are wild type, genetically modified, or combination thereof. The present invention is also directed to an oral formulation to lower serum or hepatic lipid and triglyceride concentrations, hepatic inflammation and/or insulin resistance in a patient, which comprises polymeric microcapsules containing live feruloyl esterase producing microorganisms in suspension in a pharmaceutically acceptable carrier, wherein said microcapsules are semipermeable and resistant to gastro-intestinal conditions, and wherein said microorganism are wild type, genetically modified, or combination thereof as well as methods of preventing or improving liver diseases and disorders and uses thereof.
Abstract:
The present invention describes a hydrocolloid matrix in which an enzyme is entrapped. During the cheese making process this matrix can be added to milk. The enzymes are then mainly released from the matrix after that the separation of curd from the whey has taken place.
Abstract:
A process for producing tofu wherein a delayed action solidifying agent is dispersed in heated soybean milk in a static inline mixer provided with a narrowed part and then the thus thickened matter is processed in another inline mixer provided with a separate element to thereby continuously and efficiently produce a nigari-tofu product being in a good state and having a favorable taste.
Abstract:
The invention relates to a method of preparing a hollow body, comprising preparing a suspension comprising an aqueous discontinuous phase, an aqueous continuous phase and colloidal particles, and aggregating colloidal particles at an interface between continuous and discontinuous phase, thereby forming the hollow body. The invention further relates to a hollow body obtainable by means of the method.
Abstract:
The present invention relates to a fresh food product in a 3-D form comprising a temperature-dependent jellified coating with a dairy product inside and to the process of manufacturing that food product. In particular the invention provides a fresh food product comprising a temperature-dependent external jellified coating and an internal filling comprising a dairy product which is completely enclo sed in the external jellified coating, and the process for the manufacture of this product.
Abstract:
The invention relates to a method of preparing a double emulsion comprising a) preparing an emulsion comprising at least two liquid phases by bringing a first polymer (A) and a second polymer (B) into contact with each other in a solvent, wherein the concentrations of the polymers are chosen such that, upon bringing them into contact, a phase separation occurs, thereby forming drops of a first liquid phase in a second liquid phase, wherein, in the first phase, the weight concentration of the polymer A (C A ) is higher and the weight concentration of the polymer B (C B ) is lower than the respective concentrations in the second phase; b) dispersing the emulsion in a third liquid phase, which third phase comprises the polymer A in a C A which is higher than in the second phase and the polymer B in a C B which is lower than in the second phase, thereby forming the double emulsion, comprising at least one discontinuous phase (1) - with a relatively high C A and a relatively low C B — enclosed by a surrounding phase (2) — with a relatively low C A and a relatively high C B - which discontinuous and surrounding phase are dispersed in a continuous phase (3) - with a relatively high C A and a relatively low C B ; and wherein the solvent in said liquid phases is the same or the solvents are at least, in the absence of the polymers, soluble in one another or completely miscible at 25°C.
Abstract translation:本发明涉及一种制备双重乳液的方法,其包括:a)通过使第一聚合物(A)和第二聚合物(B)在溶剂中彼此接触来制备包含至少两个液相的乳液,其中浓度 选择聚合物,使得当它们接触时,发生相分离,从而在第二液相中形成第一液相的液滴,其中在第一相中聚合物A的重量浓度(C < SUB> A SUB>)较高,聚合物B(C B B)的重量浓度低于第二相中各自的浓度; b)将乳液分散在第三液相中,该第三相包含高于第二相的C A A中的聚合物A和C B中的聚合物B, SUB>其低于第二相,从而形成双重乳液,其包含至少一个不连续相(1) - 具有相对较高的C A和更低的C B, 由相邻的相(2)包围 - 具有相对较低的C A和相对高的C B - 不连续和周围的相分散在连续的 相(3) - 具有相对较高的C A和较低的C B; 并且其中所述液相中的溶剂相同或溶剂至少在不存在聚合物的情况下彼此相溶或在25℃完全混溶。
Abstract:
The present invention relates to functional foods comprising DAO and their use for the prevention or treatment of diseases or pathological conditions associated with high levels of histamine in blood, in particular for the prevention or treatment of migraine, chronic fatigue, fibromyalgia, spondylitis and pain caused by muscle contractures.
Abstract:
The invention concerns a granulated dairy product comprising particles of milk powder, characterized in that the granulated product comprises particles of milk powder and dry particles selected from dried emulsified fat particles, whey protein isolates, maltodextrines, starches and sucrose or lactose powders, the milk powder and dry particles being agglomerated together and at least partially coated with a binding medium comprising a carbohydrate to form coated agglomerate particles of mean particle diameter between 10 and 10000 μm.